V ein of Galen aneurysmal malformations (VGAMs) classically present with cardiac failure and/or hydrocephalus in neonates and infants. 16 In rare cases, VGAMs occur later in childhood, usually with cognitive deficits. 16, 17, 19 Although the pathophysiology of this worsening cognition is not fully understood, venous hypertension with resulting venous ischemia is a major contributor that, if left untreated, may progress to global cerebral ischemia as well as a "melting-brain" syndrome. 16, 17 Other etiological factors of this decline include congenital neuronal abnormalities associated with the VGAM, acquired progressive subcortical ischemia, and/or other unidentified factors. Radiographic markers of this phenomenon have been well described and include progressive widespread subcortical calcifications, venous hypertension, and cerebral atrophy. 17, 22 The indications for intervention once subcortical calcifications are present remain controversial, and whether successful occlusion of the malformation can reverse cognitive regression has not been reported previously to our knowledge. Here, we report a case of a 5-yearold, right-handed girl with a VGAM who was treated with staged endovascular embolizations, resulting in total occlusion of the malformation. Comprehensive neurocognitive assessments were completed before intervention and at approximately 6 years after presentation. There were significant age-matched improvements in this child's neurocognitive profile over this period. We believe that timely and successful treatment of VGAMs in children may not only stabilize the associated cognitive deterioration but, in some cases, may result in reversal of these deficits.
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case report

History
The patient was born full term weighing approximately 7 pounds, and no complications with the pregnancy or birth were reported. Developmental milestones generally were reached within age-typical expectations, and the patient initially demonstrated adequate academic development during her early preschool years. The parents began to notice gradual increasing difficulty with aspects of early learning between ages 4 and 5 years. The patient received early intervention services in the school setting before being diagnosed with VGAM. Early medical history was sig-nificant for mild reactive airway disease, which was well controlled with occasional inhaler therapy.
Examination
The patient initially presented to Pediatric Neurosurgery Associates at age 5.3 years because of a several-month history of progressively worsening cognitive dysfunction, which the parents had attributed initially to problematic behavior. For example, the patient displayed new difficulty with self-care activities such as dressing herself. In addition, despite previously being aware of her surroundings, she would become disoriented on the school bus, not understanding why she was there. An initial head CT scan completed at an outside facility showed signs of VGAM (Fig. 1) . In addition, evidence of widespread dystrophic calcifications was revealed in the frontal and temporoparietal regions. This calcification primarily occurred in the subcortical white matter. Additional rim calcifications were seen involving the wall of VGAM. Initial CT findings prompted further neurological evaluation.
On examination, the patient's head circumference was 50 cm, which placed her in the 60th percentile for her age. Craniofacial features were normal, and there was no cranial bruit. A brief bedside evaluation revealed higher functions that were age appropriate. Cranial nerve and neurological examinations were normal, with no focal deficits or signs of intracranial hypertension.
After the revelation of VGAM, with extensive subcortical dystrophic calcifications, the following tests were recommended: MRI ( Fig. 2) with MR angiography, MR venography, and neuropsychological testing. Further surgical or endovascular intervention would be explored based on the results of these studies.
Presurgical Neuropsychological Assessment
Initial neuropsychological testing was completed at age 5.5 years, after diagnosis and before intervention. The battery of neuropsychological assessments included measures of intellectual functioning, verbal and visual memory, language-processing skills, visuomotor skills, and academic achievement that have been standardized and normed with large representative samples. Scores were standardized by age, with a mean of 100 and a standard deviation of 15. The parents also completed two questionnaires (Behavior Rating Inventory of Executive Function, Behavior Assessment System for Children, Second Edition) that examined the real-world manifestation of various executive functions as well as aspects of social-emotional and behavioral functioning in children.
At the time of initial assessment, findings revealed overall intellectual functioning in the extremely low range; however, there was a significant discrepancy noted between the patient's low average verbal reasoning compared with less well-developed nonverbal reasoning skills (Table 1) . Specific areas of weakness included aspects of visual-spatial processing, fine motor output (e.g., fine motor speed, motor coordination, copying activities), and emerging executive functions (e.g., attention, cognitive shifting, problem solving). Comprehension difficulties were also noted, although expressive language skills were largely intact. The parents' responses revealed significant concerns with aspects of executive and social-emotional functioning in the everyday environment. Significant concerns were also reported for anxiety, withdrawal, and atypical behaviors.
Endovascular Intervention
A 5-stage endovascular embolization process over 3 years, using flow-guided microcatheter techniques and N-butyl 2 cyanoacrylate (Trufill, Codman), was needed to completely obliterate the malformation and relieve the venous congestion (preembolization angiogram- Fig. 3A and B; postembolization angiogram- Fig. 3C and D).
Postembolization Neuropsychological Assessment
Follow-up neuropsychological testing was completed approximately 18 months after the patient's most recent embolization procedure when she was age 11.1 years. Compared with the initial assessment, updated findings suggested significant improvements in her neurocognitive profile compared with age-matched norms, as indicated by relative stability or improvement of standard scores (Table 1 ; Fig. 4 ). It is noteworthy that the presence of higher standard scores on the posttreatment assessment suggests not only sustained learning over time but also ac- celerated improvement compared with peers of the same age. For the purpose of this single-case design, significant improvement was conceptualized as performance that improved by at least 1 SD (> 15 points). Performance that improved < 1 SD was conceptualized as trending toward improvement. Verbal reasoning, language processing, and verbal memory skills were largely age appropriate as opposed to below average performance across visual-spatial tasks (e.g., visual organization, visual matching, visual memory). Significant improvements were noted for both verbal and nonverbal tasks, including measures of word knowledge, comprehension, verbal memory, visual matching, and dominant (right-)hand fine motor speed. Attention was also much improved during testing compared with the previous evaluation. Parent responses further endorsed improved attention and executive functioning in the everyday environment. Stable and improved scores suggested that the patient continued to make gains at the same rate or faster than her age-matched peers in these areas; however, immediate visual memory performance was notably lower than the prior assessment.
discussion
A VGAM represents a rare vascular anomaly characterized by arteriovenous fistulas and shunts that drain into a dilated median vein of Markowski. 1, 6, 24 The lesion is located in the midline and often receives blood supply from the limbic system, including bilateral choroidal arcades, pericallosal arteries, variable transmesencephalic arteries, and perforators of the midbrain. 18 The etiology of VGAMs is unclear, although arteriovenous shunts are PIQ/PRI = Performance Intelligence Quotient/Perceptual Reasoning Index; Tx = treatment; VIQ/VCI = Verbal Intelligence Quotient/Verbal Comprehension Index. * Neuropsychological data are presented as standard scores, with a mean of 100 and SD of 15. † Improvement was conceptualized as significant for performance that improved by at least 1 SD compared with peers of same age. ‡ Performance that improved by less than 1 SD was conceptualized as trending toward improvement.
thought to develop early in fetal development, between the 6th and 11th weeks of gestation. 25 Raybaud and Strother 24 and Raybaud et al. 25 confirmed that the vein involved with VGAMs is the embryonic precursor of the vein of Galen. VGAM has since been recognized as an embryonic choroid plexus vascular malformation. 18 The clinical presentation of VGAMs depends on a variety of factors, including the age of the child; the size and location of the lesion; the status of venous drainage such as outflow restrictions or thrombosis, which can redirect venous outflow of the brain and/or the malformation through collateral pathways such as the cavernous sinus; and/or transosseous veins. 16, 17, 22, 23 Specifically, the presence of venous hypertension can progress to cortical calcifications or even a so-called melting-brain syndrome, which represents an irreversible consequence. 16, 17 Neonates typically present with signs of significant cardiorespiratory distress and/or high-output cardiac failure. 26 Infants often present with macrocephaly, hydrocephalus, and/or seizures. 11, 13 Some infants have been found to present with developmental delay or failure to thrive associated with complicating medical factors (e.g., long-standing cerebral venous hypertension, cardiac decompensation). 4, 13 Other signs and symptoms may include cranial bruit, dilated scalp veins, proptosis, and/or recurrent epistaxis.
11 Although rare, older children and adults tend to present with relatively more innocuous symptoms, such as headache, signs associated with subarachnoid hemorrhage, or learning difficulties. 2, 11, 13 Early reports of VGAM were associated with a poor prognosis and high mortality rates. 12 The development of endovascular techniques, including recent advances in embolization procedures, has led to a notable improvement in survival and mortality rates. 3, 5, 7, 9, 21 cognitive outcome in vgam Reports of cognitive impairment and regression have been documented in the context of VGAM, which is often accompanied by radiographic markers of progressive widespread subcortical calcifications and cerebral atrophy. 17 The presence of bilateral and symmetrical cerebral calcifications has been reported previously to coincide with VGAM, and these calcifications are typically located in the subcortical venous watershed areas. 6 Reports suggest that these calcifications are often associated with brain atrophy and may represent evidence of a venous hypoxic disorder. 6 Although the presence of calcifications indicates an insult to the developing brain, the calcifications have not been shown to be predictive of neurological outcome. 18 Despite advancements in treatment approaches, only a limited number of reports have examined the neurocognitive outcomes specifically associated with VGAM. 8, 10, 18, 20, 27 On the basis of retrospective chart review and parent questionnaires, Fullerton et al. 10 reported that 39% of surviving patients presented with significant developmental delays, with worse outcomes associated with perinatal presentation, congenital heart failure, and choroidal angioarchitecture. Similar rates of cognitive impairment have been reported by other groups using various assessment measures, including the Bicêtre outcome score. 18, 20 More recently, Ellis et al. 8 examined the cognitive and functional status of a small cohort of patients (n = 5) during the most recent postembolization follow-up appointment (range 2-97 months, median 63 months). A majority of patients (n = 4) were reported to be neurologically intact without any cognitive deficits, whereas 1 patient was noted to display premorbid deficits that were unchanged and continued to persist after embolization. It is noteworthy that a majority of outcome studies among pediatric patients with VGAM primarily have used rating scales to determine neurological status rather than performance measures of neurocognitive functioning.
Neurological dysfunction may emerge for a variety of reasons. Because a VGAM forms early in fetal development, cognitive dysfunction may be reflective of alterations in the functional organization and growth of the developing brain, particularly when individuals do not present with a complicating clinical event (e.g., seizures or hemorrhage). Blood flow may be diverted away from the cerebral parenchyma by the large flow of the arteriovenous fistulas, leading to tissue damage and ischemia.
14 Tissue damage and resulting neurological changes may also result from the presence of associated complications, such as cerebral edema, hypertension, abnormalities in the venous system, venous stenosis, and/or thrombosis. All of these factors may further compromise neural tissue perfusion. 13, 15 the Present case
In the current case, the patient presented with progressive cognitive changes between ages 4 and 5 years. A recent history of learning differences was also reported, and the patient received early intervention services in the school environment, which were initiated before diagnosis and treatment of the VGAM. These services continued during subsequent school years. No other neurological complaints were reported, and the patient was asymptomatic otherwise. Neuroimaging revealed evidence of a VGAM, with widespread calcifications in the frontal and temporoparietal regions, primarily in the subcortical white matter. The patient underwent a comprehensive neuropsychological evaluation before any neurosurgical intervention at age 5.5 years. Findings indicated overall intellectual functioning in the extremely low range; however, the patient performed better on measures of verbal reasoning than on those of nonverbal reasoning. Additional areas of weakness included visual-spatial processing, fine motor output, emerging executive functions, and comprehension. No stimulant medication was given. The patient underwent an updated comprehensive evaluation approximately 18 months after her most recent embolization procedure at age 11.1 years. Updated results continued to demonstrate a similar pattern of strengths and weaknesses, although the patient exhibited notable improvement in a variety of cognitive domains compared with age-matched norms.
Improvements in neurocognitive functioning may be attributable to multiple factors. First, the patient continued to develop, mature, and be exposed to academic instruction over the 6 years between pre-and posttreatment evaluations. Hence, some improvements may be attributed to typical maturational processes associated with childhood. Second, the embolization procedures have improved cerebral blood flow and relieved venous hypertension, which may contribute to improved neuronal function in various parts of the brain.
Although it is likely that extensive subcortical calcifications are radiographic markers of cognitive impairment, a direct causation and radiographic-clinical correlation has yet to be established definitively. It has been reported that the presence of subcortical calcifications is a marker of severe and potentially irreversible cognitive impairment. 6, [16] [17] [18] Less is known about the impact of embolization procedures on improving the cognitive functioning in these individuals. Despite notable areas of neurocognitive weakness before the initiation of treatment, the patient in this case report has continued to make gains in her development compared with peers of the same age. Results continued to suggest greater right hemisphere and frontal lobe disruption compared with largely preserved left hemisphere functioning. Nevertheless, improvements were seen on tasks across domains, including measures of language processing, visual-spatial processing, memory, and attention. We speculate that improvements may be associated, to a certain extent, with the embolization procedures. Without treatment, it is possible that further cognitive deterioration would have continued. To our knowledge, this is the first report of a child with VGAM undergoing comprehensive neuropsychological evaluations pre-and postembolization. This report suggests that timely and successful treatment of VGAMs in children may not only stabilize the associated cognitive deterioration but, in some cases, may ameliorate these deficits.
references
